Thus, a better understanding of how IGF-I and TGF-β signaling pathways are mutually interconnected is likely to unveil novel targets for the therapeutic intervention of many mediators of lung fibrosis [14]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.